000 01179 a2200325 4500
005 20250517182235.0
264 0 _c20180705
008 201807s 0 0 eng d
022 _a1365-2354
024 7 _a10.1111/ecc.12787
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEleutherakis-Papaiakovou, Evangelos
245 0 0 _aAntiresorptive treatment-associated ONJ.
_h[electronic resource]
260 _bEuropean journal of cancer care
_cNov 2017
500 _aPublication Type: Journal Article; Review
650 0 4 _aBisphosphonate-Associated Osteonecrosis of the Jaw
_xetiology
650 0 4 _aBone Density Conservation Agents
_xadverse effects
650 0 4 _aBone Neoplasms
_xdrug therapy
650 0 4 _aDenosumab
_xadverse effects
650 0 4 _aDiphosphonates
_xadverse effects
650 0 4 _aHumans
650 0 4 _aMass Screening
650 0 4 _aOral Hygiene
650 0 4 _aRisk Factors
650 0 4 _aRisk Reduction Behavior
650 0 4 _aStomatognathic Diseases
_xdiagnosis
700 1 _aBamias, Aristotelis
773 0 _tEuropean journal of cancer care
_gvol. 26
_gno. 6
856 4 0 _uhttps://doi.org/10.1111/ecc.12787
_zAvailable from publisher's website
999 _c27715965
_d27715965